Reading the tape
NASDAQ: ATEC
Alphatec Holdings, Inc.
Healthcare · Medical - Devices
Market Cap
$1.54B
52w High
$23.29
52w Low
$9.11
P/E
-10.65
Volume
3.39M
Outstanding Shares
151.36M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -15.82%Revenue (TTM): 24.95%FCF (TTM): 102.01%P/S: 36th pct
What changed
The stock fell 15.82% over the last year. Revenue grew 24.95% over the trailing twelve months. Operating margin moved from -22.27% to -10.3%. Free cash flow grew 102.01% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -10.3%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders.
CEOPatrick S. Miles
SectorHealthcare
IndustryMedical - Devices
Employees867
IPO dateJun 12, 2006
Valuation
Forward P/E—
EV/EBITDA-91.10
Enterprise value$3.62B
Stock splits
Aug 25, 2016↓ Reverse
Every 12 shares became 1
Profitability & growth
Revenue growth20.44%
Gross margin67.11%▲0.33%vs FY2024
Operating margin-10.3%▲51.73%vs FY2024
ROE-397.9%▲76.85%vs FY2024
Analyst consensus
RatingBuy
Target price$25.00▲145.70%
13
Buy
2
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est -$0.01 · Revenue est $197.51M
View